Intelligence Platform
Patents
Browse 1,641 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 10780108
RNAi agents for Hepatitis B virus infection
granted patentUS 10774390
Methods and compositions for modulating PrfA mediated virulence gene activation in Listeri
granted patentUS 10765687
Methods and compounds to inhibit enveloped virus release
granted patentUS 10759774
Inhibitors of hepatitis B virus targeting capsid assembly
granted patentUS 10745474
Methods of treating inflammation associated airway diseases and viral infections
granted patentUS 10738035
Hepatitis B antiviral agents
granted patentUS 10729688
Hepatitis B antiviral agents
granted patentUS 10729756
Viable viruses with foreign tags
granted patentUS 10723733
Hepatitis B antiviral agents
granted patentUS 10724007
Development of dengue virus vaccine components
granted patentUS 10717732
Inhibitors of influenza virus replication, application methods and uses thereof
granted patentUS 10711029
Beta-d-2β²-deoxy-2β²-alpha-fluoro-2β²-beta-c-substituted-4β²fluoro-n6-substituted-6-amino-2-su
granted patentUS 10702528
Hepatitis B antiviral agents
granted patentUS 10688174
Method of conferring a protective immune response to norovirus
granted patentUS 10682368
Methods of treating feline coronavirus infections
granted patentUS 10683316
Synthetic catalase/superoxide dismutase mimetics and methods for treating viral infections
granted patentUS 10675341
Parenteral norovirus vaccine formulations
granted patentUS 10676498
Processes for the preparation of sofosbuvir and intermediates thereof
granted patentUS 10662416
Engineered meganucleases specific for recognition sequences in the hepatitis B virus genom
granted patentUS 10662440
Self-limiting viral vectors encoding nucleases
granted patentUS 10662238
Single domain VHH antibodies directed to norovirus GI.1 and GII.4 and their use
granted patentUS 10653782
Retroviral particles expressing Sirt1 embedded within PPCN
granted patentUS 10655109
Recombinant respiratory syncytial virus stains with mutations in the M2-2 ORF providing a
granted patentUS 10654898
Recombinant human/bovine parainfluenza virus 3 (B/HPIV3) expressing a chimeric RSV/BPIV3 F
granted